Ertapenem FDA Link

A carbapenem derivative antibacterial agent that is more stable to renal dehydropeptidase I than IMIPENEM, but does not need to be given with an enzyme inhibitor such as CILASTATIN. It is used in the treatment of Gram-positive and Gram-negative bacterial infections including intra-abdominal infections, acute gynecological infections, complicated urinary tract infections, skin infections, and respiratory tract infections. It is also used to prevent infection in colorectal surgery.

Also Known As:

Invanz; Ertapenem Sodium; Invanoz; (4R,5R,6S)- 3- ((3S,5S)- 5- ((3- Carboxyphenyl)carbamoyl)pyrrolidin- 3- yl)sulfanyl- 6- (1- hydroxyethyl)- 4- methyl- 7- oxo- 1- azabicyclo(3.2.0)hept- 2- ene- 2- carboxylic acid

Organic Chemicals: 140
- Amides: 2487
  - Lactams: 2278
    - beta-Lactams: 2435
      - Carbapenems: 5149
        Ertapenem: 558
Heterocyclic Compounds: 207
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - beta-Lactams: 2435
      - Carbapenems: 5149
        Ertapenem: 558

Shire Yang Tan Selected Research

Shire Yang Tan Research Topics

Disease

Drug/Important Bio-Agent (IBA)

Therapy/Procedure